Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 266,000 | 298,000 | 307,000 | 299,000 | 284,000 |
| Cost of Goods | 44,000 | 48,000 | 66,000 | 79,000 | 38,000 |
| Gross Profit | 221,000 | 250,000 | 241,000 | 220,000 | 246,000 |
| Operating Expenses | 155,000 | 205,000 | 205,000 | 338,000 | 171,000 |
| Operating Income | 66,000 | 46,000 | 35,000 | -118,000 | 75,000 |
| Interest Expense | 12,000 | 12,000 | 11,000 | 9,000 | 9,000 |
| Other Income | 5,000 | 4,000 | 6,000 | 6,000 | 7,000 |
| Pre-tax Income | 59,000 | 38,000 | 30,000 | -121,000 | 73,000 |
| Income Tax | 11,000 | 17,000 | 8,000 | -23,000 | 11,000 |
| Net Income Continuous | 47,000 | 21,000 | 22,000 | -97,000 | 61,000 |
| Net Income | $47,000 | $21,000 | $22,000 | $-97,000 | $61,000 |
| EPS Basic Total Ops | 0.38 | 0.16 | 0.16 | -0.72 | 0.45 |
| EPS Basic Continuous Ops | 0.38 | 0.16 | 0.17 | -0.72 | 0.45 |
| EPS Diluted Total Ops | 0.38 | 0.16 | 0.16 | -0.72 | 0.45 |
| EPS Diluted Continuous Ops | 0.38 | 0.16 | 0.17 | -0.72 | 0.45 |
| EPS Diluted Before Non-Recurring Items | 0.41 | 0.32 | 0.54 | 0.44 | N/A |
| EBITDA(a) | $72,000 | $54,000 | $44,000 | $-112,000 | $80,000 |